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Background: There is growing evidence that inflammatory processes of activated microglia could play an
important role in the progression of nerve cell damage in neurodegenerative disorders such as Parkinson’s disease
and Alzheimer’s disease which harbor features of chronic microglial activation, though the precise mechanism is
unknown. In this study, we presented in vivo and ex vivo experimental evidences indicating that activated microglia
could exacerbate the survival of axotomized dopaminergic neurons and that appropriate inactivation of microglia
could be neuroprotective.
Results: The transection of medial forebrain bundle (MFB) of a rat induced loss of dopaminergic neurons in a time-
dependent manner and accompanied with microglial activation. Along with microglial activation, production of
reactive oxygen species (ROS) was upregulated and TH/OX6/hydroethidine triple-immunofluorescence showed that
the microglia mainly produced ROS. When the activated microglial cells that were isolated from the substantia
nigra of the MFB axotomized animal, were transplanted into the substantia nigra of which MFB had been
transected at 7 days ago, the survival rate of axotomized dopaminergic neurons was significantly reduced as
compared with sham control. Meanwhile, when the microglial activation was attenuated by administration of
tuftsin fragment 1-3 (microglia inhibitory factor) into the lateral ventricle using mini-osmotic pump, the survival rate
of axotomized dopaminergic neurons was increased.
Conclusion: The present study suggests that activated microglia could actively produce and secrete unfavorable
toxic substances, such as ROS, which could accelerate dopaminergic neuronal cell loss. So, well-controlled blockade
of microglial activation might be neuroprotective in some neuropathological conditions.
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Microglia, the primary immune effector cells in the central
nervous system (CNS), are distributed throughout the
CNS and constitute approximately 10-20% of the total glial
cell population within the brain [1]. Under physiological
conditions, microglia are important in maintenance
and restoration of the brain by scavenging the invading
infectious agents and any by removing foreign materials,
dying cells, or random cellular debris. However, if microglia
become activated in response to injuries to the brain or to
immunologic stimuli, they undergo morphological changes,* Correspondence: jbl0719@naver.com
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reproduction in any medium, provided the orproliferate, and increase the expression of major histo-
compatibility (MHC) complex molecules and complement
receptor type 3. Activated microglia also release a variety of
proinflammatory soluble factors [2-5]. Microglial activation
is a histopathological hallmark of several neurodegenerative
disorders, including Parkinson’s disease, Alzheimer’s dis-
ease, multiple sclerosis, and the AIDS dementia complex
[6-9]. Over the last ten years, there has been an increased
interest in microglia because microglial activation could
be a risk factor triggering a cascade of events leading to
progressive neuronal degeneration [10,11].
Parkinson’s disease (PD) is a neurodegenerative disorder
characterized by progressive loss of dopaminergic (DA)
neurons in the substantia nigra pars compacta (SNpc).
Although the cause of DA neuronal death in PD remains
unclear, accumulating evidences strongly suggest thattd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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may be one of the factors contributing to the pathogenesis
of PD. For example, the accumulation of activated micro-
glia and up-regulation of several inflammatory cytokines
has been observed in association with degeneration of
DA neurons in the substantia nigra (SN) of postmortem
PD brain and animal models of PD treated with the admin-
istration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
(MPTP), 6-hydroxydopamine (6-OHDA), or rotenone
[12-17]. The intranigral or systemic administration of
lipopolysaccharide (LPS), which is a gram-negative
bacteriotoxin that activates microglial cells, can selectively
initiate DA neuronal cell death [18,19], though LPS does
not seem to have a direct harmful effect on neurons
[20]. These events were attenuated by pretreatment with
anti-inflammatory agents, such as naloxone [21] and
minocycline [22]. Many epidemiological studies of PD
indicate that anti-inflammatory medications have been
identified as potentially effective in reducing the risk of
PD [23-25]. These findings strongly suggest that microglial
activation-derived oxidative stress and neuroinflammation
could increase neurotoxicity and might play an important
role in DA neuronal degeneration.
In this study, we characterized the activated microglia in
SN following medial forebrain bundle (MFB) transection
by using a rat MHC class II marker (OX6) and phagocytic
marker (ED1), and furthermore, we demonstrated produc-
tion of ROS from activated microglia using hydroethidine.
After that, we examined whether administration of
activated microglia could accelerate DA neuronal degener-
ation. In particular, we also showed that the inactivation
of microglia with a microglia inhibitory factor (tuftsin
fragment 1-3) could be neuroprotective by demonstrating
a high survival rate of axotomized DA neurons in rats.
Based on these findings, we indicated that activated
microglia could have a deteriorative effect on axotomized
DA neuronal survival and that well-controlled blockade of
microglial activation might be neuroprotective.
Methods
Animal care and MFB transection
All experimental procedures performed on the animals
were approved by the Animal Review Board of the Eulji
University (EUIACUC-10-13) in accordance with the
National Institutes of Health Guide for the Care and Use
of Laboratory Animals (NIH Publication No. 80-23, revised
1996). All efforts were made to minimize the numbers
of animals used and ensure minimal suffering of those
animals. Adult male Wistar rats (n = 90, Charles River
Lab, Wilmington, USA) weighing 250-300 g at the time
of surgery were used for the following experiments:
immunohistochemistry and hydroethidine histochemistry
(n = 8), western blot assay (n = 12), isolation of micro-
glia (n = 12), transplantation of microglia (n = 12), andadministration of tuftsin fragment 1-3 (n = 46). Animals
were housed in groups of two or three, with food and
water in a room maintained at constant room temperature
(20 ∼ 22°C) with a 12:12-h light-dark cycle.
The MFB transection was carried out as previously de-
scribed [26]. Animals were anesthetized by intraperitoneal
injection of ketamine (70 mg/kg) and xylazine (8 mg/kg)
mixture and secured in a stereotactic apparatus (Stoelting
Co., Wood Dale, USA). After exposure of the skull, a small
hole was made with a dental drill in the right side of the
skull at coordinates 3.0 mm caudal to bregma and 2.8 mm
right to midline. A cannula, housing a retractable wire
knife (David Kopf Instruments, Tujunga, USA), was
lowered through the hole to a depth of 9.0 mm from
the dural surface and then the wire knife was extended
2.2 mm toward the midline, and the knife was slowly
raised 3.0 mm and subsequently lowered back to its
original position to ensure complete excision of the whole
MFB. After surgery, animals were kept on a heating plate
at 37°C until recovery was complete. The contralateral
side of the brain was used as internal control.
Tuftsin fragment 1-3 administration using
mini-osmotic pump
Following unilateral MFB transection, under consecutive
anesthesia, a cannula (Brain Infusion Kit II, Alzet; Durect
Co., Cupertino, USA) which was connected to a mini-
osmotic pump (Alzet) by a vinyl catheter tube was stereo-
tactically implanted into the contralateral lateral ventricle
(0.8 mm cranial to bregma, 1.5 mm left to midline, and
4.0 mm depth from dural surface). All infusions were
performed using a 200 μl mini-osmotic pump (Model
2002 for 2 week-group and Model 2004 for 4 week-group
animals). The pumps were designed to infuse continuously
either tuftsin fragment 1-3 (30 ng/kg per day; Peptron,
Daejeon, Korea) or vehicle solution (artificial CSF; CMA
Microdialysis AB, Solna, Sweden) for 14 days or 28 days.
Dosage of tuftsin fragment 1-3 was chosen in accordance
with that of previous studies [27-29]. The connected
osmotic pump was inserted subcutaneously in the back
of the animal through the interscapular pocket. The
scalp was sutured and then the animal was removed from
the stereotactic frame and allowed to recover from surgery
in a warm environment. The animals were carefully
observed and monitored for several hours after recovery
from anesthesia.
Isolation and culture of microglia from adult rat midbrain
The isolation of microglial cells from adult rats was
performed using methods previously described by Brewer
and Torricelli [30], with some modifications. Following
cardiac perfusion with normal saline to remove the per-
ipheral blood cells, the rat brain was rapidly extracted and
placed on a brain blocker (David Kopf Instruments), and
Song et al. BMC Neuroscience 2013, 14:112 Page 3 of 13
http://www.biomedcentral.com/1471-2202/14/112sliced into about 5 mm coronal block including SN of
which the position was determined according to the
Paxinos and Watson [31]. The tissue block was cut
through the arbitrary horizontal line crossing the inferior
border of the both medial geniculate bodies, and then cut
through the arbitrary vertical line dividing SN into right
and left halves.
The isolated tissue blocks were dissected out in ice-
cold HAGB [HA medium (Brain Bits, Springfield, USA)
supplemented with 2% B-27 (Invitrogen, Carlsbad, USA)
and 0.5 mm Glutamax (Invitrogen)]. They were chopped
into pieces lesser than 0.5 mm3 using MacIlwain tissue
chopper (The Mickle Lab., Guildford, UK) and digested for
30 min at 30°C with papain (30 units/ml; Worthington,
Lakewood, USA) in calcium-free HA medium (Brain Bits)
with 0.5 mm Glutamax. The digested tissues were trans-
ferred to a 15 ml tube containing 2 ml HABG and carefully
triturated 15 times through a 5 ml plastic pipette. Samples
were allowed to settle by gravity for about 2 min, and
then the supernatant containing dissociated neurons
and neuroglia was transferred to a fresh tube. Twice more,
the sediment was suspended in 2 ml HABG, triturated 15
times, allowed to settle for 2 min and the supernatants
combined until 6 ml of supernatant was collected. The
collected supernatant was loaded upon the top of the
prepared OptiPrep step gradient (Sigma-Aldrich Co., St.
Louis, USA) solution. The OptiPrep step gradient was
made in four 1 ml steps of 17.0, 13.5, 10.0, and 7.5%
OptiPrep gradient in HABG. The cell suspension was
centrifuged at 800 g for 15 min at room temperature
and the pellet, which is enriched with microglia, was
harvested.
For the transplantation of activated microglia, the pellet
which was collected from SN treated with MFB transection
7 days ago was resuspended with HBSS (Gibco, Carlsbad,
USA) and transplanted immediately. For immunofluores-
cence, the pellet was resuspended in 2 ml DMEM and
50,000 cells were plated on Ø 12-mm glass coverslips,
which had previously been coated with poly-D-lysine
(70–150 kDa, Sigma-Aldrich Co.) at 37°C overnight. After
allowing cells to adhere for 2 h in 37°C incubator at 5%
CO2, the coverslip was employed for immunofluorescence.
Stereotactic intranigral transplantation of activated
microglia
One week after unilateral MFB transection, the isolated
microglia were transplanted into the operated (ipsilateral)
side of SN. Rats were deeply anesthetized and placed in
a stereotaxic frame with microinjector unit (David Kofp
Instruments). Stereotactic coordinates for the injection
were 5.0 mm caudal to bregma, 1.5 mm right to midline,
and 7.0 mm from dural surface. A total of 1×105 microglia
suspended in 200 μl HBSS buffer was injected into the
ipsilateral SN with a Hamilton syringe (22-gage). Theinjections were made at a rate of 100 μl/min and the
needle was left in place for 2 min after each injection
and slowly withdrawn. Sham operated animals were
infused with the same volume of HBSS buffer alone.
The rats were placed back into cages where they were
allowed to recover and were sacrificed at 7 days post
transplantation.
Sample preparation and immunohistochemistry
At 7, 14, and 28 days after unilateral MFB transection,
or 14 and 28 days following administration of tuftsin
fragment 1-3, or 7 days after transplantation of activated
microglia, the animals were deeply anesthetized. The ani-
mals were perfused transcardially with 100 ml of ice-cold
0.1 M sodium phosphate buffer (PB; pH 7.6) containing
0.5% sodium nitrite and 10 U/ml heparin, followed by
200 ml of 4% paraformaldehyde in 0.1 M PB. The brain
was carefully removed from the skull and post-fixed for
12 h in the same fixative and infiltrated with 30% sucrose
solution for 12-24 h at 4°C until they sank. The brain was
then placed on a brain blocker (David Kopf Instruments)
and sliced into 5 mm coronal block including the SN. The
coronal blocks were rapidly frozen in 2-methylbutane
chilled on dry ice and mounted in Tissue-Tek OCT com-
pound (Sakura Finetechnical Co., Tokyo, Japan). Serial
coronal sections with 40 μm-thickness were obtained on a
Cryostat Microtome (Leica Microsystems Inc., Wetzlar,
Germany).
Sections were washed for 10 min in 0.1 M PB
containing 0.9% saline (PBS) and endogenous peroxidase
activity was quenched by incubating the tissue sections
with 0.3% hydrogen peroxide in PBS for 30 min. The
sections were rinsed in 0.1 M PBS and incubated in
0.1 M PBS containing 5% normal goat serum and 0.1%
Triton X-100 for 30 min to reduce non-specific staining.
The sections were then incubated with primary antibodies,
diluted in 0.1 M PBS containing 0.1% Triton X-100 (PBST)
for 16 h at 4°C. Primary antibodies used in this study
were as follows: rabbit anti-tyrosine hydroxylase (TH)
monoclonal antibody (1:2000; Chemicon, Temecula, USA),
mouse monoclonal anti-rat CD11b antibody (OX42; 1:500;
Serotec, Oxford, UK), mouse monoclonal anti-rat MHC
class II antibody (OX6; 1:500; Serotec), and mouse mono-
clonal anti-rat CD68 antibody (ED1; 1:500; Serotec). OX42
was used as a pan-microglial cell marker, OX6 and ED1
were used for identification of activated microglia, since it
has been reported that the expression of ED1 is upregulated
in microglia during phagocytosis [32] and the activated
microglia express high level of MHC class II [3]. Sections
were washed in PBST and incubated for 2 h with
biotinylated goat anti-rabbit IgG (1:200; Vector Labs,
Burlingame, USA) for TH or biotinylated goat anti-mouse
IgG (1:200; Vector Labs) for OX42, OX6, and ED1. Fol-
lowing rinses, sections were exposed to avidin-biotin
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1 h prior to incubation during 3-5 min for peroxidase
detection using 3,3′-diaminobenzidine tetrahydrochloride
(DAB; Sigma-Aldrich Co.). Light photomicrographic
images were acquired on a Nikon Optiphot microscope
(Nikon Inc., Tokyo, Japan) fitted with a Nikon digital
camera (DXM1200; Nikon Inc.), using Nikon ACT-1
image capture software (version 2.2; Nikon Inc.).Immunocytofluorescence labeling and semi-quantitative
analysis
Indirect immunofluorescent labeling with primary anti-
bodies against CD11b (OX42; microglia), GFAP (astro-
cytes), and NeuN (neurons) were performed to assess the
cell type and purity of the isolated microglia from adult
rat brains. We also conducted OX6 and iNOS (inducible
nitric oxide synthase) immunofluorescent labeling to in-
vestigate whether microglial cells isolated from ipsilateral
SN were activated. Cells plated on 12-mm glass coverslips
were fixed with 4% paraformaldehyde and 4% sucrose so-
lution for 10 min. Following incubation in PBS containing
10% normal horse serum for 30 min, the cells were
incubated overnight at 4°C with OX42 (1:100), GFAP
(mouse monoclonal anti-GFAP antibody, 1:100, Chemicon),
NeuN (mouse monoclonal anti-NeuN antibody, 1:100,
Chemicon), OX6 (1:100), and iNOS (goat polyclonal
anti-iNOS antibody, 1:100, Chemicon). After rinsing in
PBS, a Cy3-conjugated horse anti-mouse secondary
antibody (1:200; Jackson ImmunoResearch Lab., West
Grove, USA) for OX42, GFAP, NeuN, and OX6 or Cy3-
conjugated horse anti-goat secondary antibody (1:200;
Jackson ImmunoResearch Lab.) for iNOS was applied
for 2 h at room temperature. The coverslips were then
incubated with Hoechst 33342 (Cell Signaling Tech-
nology Inc., Beverly, USA) to visualize the nuclei, and
mounted upon slide glass with Vector-shield medium
(Vector Labs).
For semi-quantitative analysis, the number of OX42,
GFAP, NeuN, OX6, and iNOS-immunoreactive (−ir) cells
and the total number of Hoechst positive nuclei were
counted by two of the authors independently. Ten
counting fields (at 200 magnifications; one counting
field is 700 × 500 um) in each coverslip were selected
randomly, and the images were captured with an Olympus
Ax 70 microscope (Olympus Inc., Tokyo, Japan) fitted
with a Carl Zeiss AxioCam MRC digital camera (Carl
Zeiss Inc., Jena, Germany). The percentage was calculated
by dividing the average number of OX42-ir, GFAP-ir,
NeuN-ir, OX6-ir, and iNOS-ir cells by the average number
of Hoechst positive nuclei. Three experimental animals
were used. The statistical significance was assessed by
one-way ANOVA followed by Dunnertt’s test. Values of
P < 0.05 were considered significant.In situ detection of O2
- and O2
- -derived oxidant production
and OX6/TH double immunofluorescence
In situ visualization of reactive oxygen species (ROS, O2
–
and O2
--derived oxidant) generated by microglia was
assessed by hydroethidine (HEt) histochemistry [33,34].
At 7, 14, and 28 days after unilateral MFB transection,
HEt (2 mg/kg in saline containing 1% dimethysulfoxide;
Molecular Probes, Eugene, USA) was administered intra-
peritoneally. After 30 min, the brains were harvested as
described above. Midbrain sections mounted onto gelatin-
coated glass slides were examined for oxidized product of
hydroethidine, ethidium accumulation, by fluorescence
microscopy (excitation, 510 nm; emission, 580 nm).
OX6/TH double immunofluorescence labeling was
performed at HEt treated sections to examine whether
activated microglia produce ROS. Sections were incubated
with PBS containing 10% normal goat serum for 30 min,
followed by the application of the mixture of TH (1:200)
and OX6 (1:50) antibodies for 16 h at 4°C. After rinsing in
PBS, a mixture of AMCA-conjugated donkey anti-rabbit
secondary antibody (1:200, Jackson ImmunoResearch Lab.)
and FITC-conjugated donkey anti-mouse secondary anti-
body (1:200, Jackson ImmunoResearch Lab.) was applied
for 2 h at room temperature. All procedures were con-
ducted in a dark condition.Stereological cell count of TH-immunoreactive DA neurons
Stereological unbiased procedures using the optical dis-
sector method were carried out to provide the percentages
of TH-immunoreactive (TH-ir) neurons in the SN, as
previously described [26]. Following every fourth section
through the entire SN (levels: AP-4.5 mm to-6.3 mm to
bregma) was sampled into three series of sections, TH im-
munohistochemistry was performed as described above.
The borders of the SN at all levels were defined to Kirik’s
method [35]. StereoInvestigator software (MicroBrightField
Inc., Williston, USA) was used to delineate the one side
of SN at 4× objectives and generate 20% counting area.
A counting frame (1600 μm2) was placed randomly and
systematically moved through all counting areas. Actual
counting was done under 630 magnifications. The sam-
pling volume in the Z-axis extended 25 μm deep after
excluding 3 μm from both top and bottom surfaces. The
total number of the ipsilateral or contralateral TH-ir
neurons was obtained by summing the profiles of each
section and the average number was estimated.
To examine the survival rate of TH-ir neurons following
administration of tuftsin fragment 1-3 or transplantation
of activated microglia, the survival percentages of TH-ir
neurons in the ipsilateral SN were calculated by dividing
the average number of the ipsilateral TH-ir neurons by
the contralateral ones. Five to seven animals at each time
point were used.
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The midbrain tissue blocks including the ipsilateral or
the contralateral SN were obtained as described above and
homogenized in a protein extraction solution (Pro-prep
protein extraction solution; Intron Biotech, Seoul, Korea)
using polytron homogenizer. Protein concentrations were
determined using a Bio-Rad colorimetric protein assay kit
following the manufacture’s guide (Bio-Rad, Hercules,
USA). Equal amount (20 mg) of protein were loaded and
separated by sodium dodecyl sulfate (SDS)-polyacrylamide
gel electrophoresis, and transferred onto a nitrocellulose
membrane (Invitrogen). Membranes were blocked with 5%
nonfat milk for 1 h and incubated overnight at 4°C with
TH (1:5000), OX42 (1:2000), OX6 (1:2000), ED1 (1:2000),
and mouse monoclonal anti-beta-actin (1:5000, Chemicon)
antibodies. Horseradish peroxidase-conjugated antibody
(1:500; Amersham Pharmacia Biotech, Piscataway, USA)
was used as a secondary antibody. Band detection was
performed using the enhanced chemiluminescence (ECL)
detection system (Amersham Pharmacia Biotech). For
semi-quantitative analyses, the densities of each band
on immunoblots were normalized against that of beta
actin by using the Image J software.
Results
MFB transection induced gradual loss of DA neurons and
microglial activation
Compared with the contralateral SN, a time-dependent
decrease of the number of the TH-ir DA neurons was
noted in the ipsilateral SN (Figure 1A). When the amount
of the TH protein in the ipsilateral SN was measured
by western blot assay, the percentage of that to the
contralateral counterpart was 94.4 ± 6.7% (mean ± SD),
43.8 ± 10.5%, and 36.6 ± 9.9% at 7, 14, 28 days post-lesion
(dpl), respectively (Figure 1B, C).
The progressive loss of DA neurons was accompanied
by microglial activation. In the contralateral SN, resting
microglia characterized by small cell bodies and long,
slender processes with weak OX42 immunoreactivity
were distributed throughout SN. There were little or no
detection of OX6 or ED1-ir cells in the contralateral SN
parenchyma, except for a few OX6-ir or ED1-ir cells
around the blood vessels which were believed to be
perivascular cells. However, a considerable number of
activated microglia retaining enlarged soma and shorter,
thicken cytoplasmic processes were crowded in the ipsilat-
eral SN after unilateral MFB transection. They showed in-
tense OX42, OX6, and ED1 immunoreactivity (Figure 1A).
To confirm the results of the immunohistochemistry, we
examined the changes of the protein level of CD11b
(OX42), MHC class II (OX6), and CD68 (ED1) by western
blot assay. Quantification of the bands by densitometry re-
vealed that the expression levels of CD11b (OX42), MHC
class II (OX6), and CD68 (ED1) in the ipsilateral SN wereabove 5 folds higher than that of the contralateral SN
(Figure 1B, C).
OX6-positive activated microglia produce superoxide
Recent accumulating in vivo and in vitro evidence
suggests that activated microglia produce ROS (O2
-and
O2
--derived oxidant) [36]. To investigate whether ROS
production has changed with the progress of neurodegen-
eration in the ipsilateral SN, we performed in situ
visualization of ROS (O2
-and O2
- -derived oxidant) with
fluorescence of ethidium, which is oxidized hydroethidine
in vivo. The fluorescent products of oxidized hydroethidine
(i.e., ethidium accumulation) were significantly increased at
7 dpl in the ipsilateral SN and decreased gradually by 28
dpl (Figure 2A). The distribution of ethidium fluorescent
was correctly matched with that of activated (OX6-ir or
ED1-ir) microglia.
Later, we conducted TH/OX6 double immunofluores-
cence labeling to detect what kind of cells produce ROS,
as well as to confirm the spatial relationship between
activated microglia and TH-ir DA neurons. The results
showed that numerous ethidium fluorescent nuclei were
embedded within the cell body of OX6-ir microglia (ar-
rows, Figure 2B). Furthermore, these activated microglia
retaining ethidium fluorescence were closely besieged
with TH-ir DA neurons (Figure 2B).
Transplantation of activated microglia exacerbates the
degeneration of axotomized DA neurons
After density gradient centrifugation, a distinct opaque
band and a small pellet could be obtained (Figure 3A).
According to a previous report [30], the opaque band
and its upper fraction is enriched with oligodendrocytes
and cell debris. There is enrichment for neurons from
the lower edge of the dense band to 0.5 ml from bottom
of the tube and the loose pellet on the bottom contains
microglia. Therefore, in this study, only the pellet fraction
was collected and used. Cell yields reached 1.28 × 106 cells
per 1 mg of SN tissue block. Immunofluorescent labeling
of the isolated pellet indicated a highly homogeneous
population of very small and round cells, which were
uniformly stained with microglial marker (OX42; ≥ 51%),
but were negative with the astroglial (GFAP; ≤ 0.5%) or
neuronal markers (NeuN; ≤ 0.3%) (Figure 3B, C).
To confirm whether the mesencephalic microglia isolated
from the ipsilateral SN have retained the characteristics of
activated microglia, immunofluorescent staining of OX6
and iNOS was conducted. A great number of microglia
prepared from the ipsilateral SN at 7 dpl after MFB
transection were highly immunoreactive with OX6 and
iNOS. The percentage of OX6-ir cells/Hoechst-ir cells is
14.3 ± 2.6% and the percentage of iNOS-ir cells/Hoechst-ir
is 18.8 ± 3.2%. Some of them showed typical morphologic
characteristics of activated microglia, with large soma and
Figure 1 MFB transection induces significant loss of TH-ir neurons and microglial activation in the ipsilateral SN. (A) TH, OX42, OX6, and
ED1 immunohistochemistry in the contralateral (Cont) and ipsilateral (Ipsl) SN at 7, 14, and 28 days post-lesion (dpl) of unilateral MFB transection.
Insets in (A) represent higher magnification of each photograph. Significant reduction in the number of TH-ir neurons is noted in the ipsilateral
SN at 14 and 28 dpl. The resting ramified microglia showing weak OX42 immunoreactivity are distributed evenly in the contralateral SN and they
are not immunolabeled with ED1 or OX6. However, in the ipsilateral SN, quite numerous activated microglia with increased OX42
immunoreactivity are found and they are also immunoreactive with OX6 and ED1. The activated microglia retain enlarged soma and shorter,
thicken cytoplasmic processes. Scale bar represents 100 μm. (B) Changes in expression level of TH, OX42, OX6, and ED1 by western blot assay.
(C) Quantification of results from western blot assay in (B). The density of each TH, OX42, OX6, and ED1 band was normalized against that of
beta-actin. Values were normalized to control and expressed as the mean ± S.E.M. (n = 3). *P < 0.05 compared with value from control (ANOVA
with post hoc Student’s t test).
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contralateral SN displayed OX6-negative immunopheno-
type (Figure 3D).
When compared with the sham control, a clear reduction
of TH-ir cell number/density was obvious in the ipsilateral
SN where the activated microglia had been transplanted
(Figure 4A). Subsequent unbiased stereological analysis
confirmed that the proportion of the TH-ir neurons inthe ipsilateral SN of activated microglia transplanted
groups was 36.4 ± 3.2% and that of sham control groups
was 45.1 ± 2.3% (Figure 4B).
Inhibition of microglial activation attenuates DA neuronal
cell loss
Tuftsin fragment 1-3 treated animals were monitored for
overall health, weight loss, and activity during the course
Figure 2 The activated microglia produce ROS. Hydroethidine (2 mg/kg), which can be converted to ethidium by ROS, was injected to the
experimental animals intraperitoneally. After 30 min, brains were harvested and sections of SN were prepared for hydroethidine histochemistry to
detect superoxide. (A) Representative ethidium fluorescence of the contralateral (Cont) and ipsilateral (Ipsi) SN at 7, 14, and 28 dpl following
unilateral MFB transection. The number of ethidium fluorescent spots increases to peak level at 7 dpl, and then decreases gradually by 28 dpl.
(B) Immunofluorescent images of TH, OX6, ethidium (ET), and their merged image in the ipsilateral SN at 14 dpl. Many OX6 immunoreactive
microglia are co-localized with ethidium (arrows). Scale bars represent 50 μm.
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behavioral changes compared with the vehicle-treated or
un-operated animals.
Tuftsin fragment 1-3 administration decreased the MHC
class II (OX6) and CD68 (ED1) expression level above 2
folds lower than that of the vehicle treated group at 14 dpl
(Figure 5A, B) and showed dramatic decrease in intensities
of OX6 and ED1 immunoreactivities (Figure 5C). In
accordance with suppression of microglial activation,
the DA neuronal cell loss was attenuated by administration
of tuftsin fragment 1-3. In the vehicle administrated group,
the proportions of TH-ir neurons in the ipsilateral SN
were 61.0 ± 4.0% at 14 dpl and 35.2 ± 2.6% at 28 dpl. On
the other hand, the proportions of that in the tuftsin frag-
ment 1-3 treated groups were 80.8 ± 4.8% at 14 dpl and
60.3 ± 5.1% at 28 dpl (Figure 5D).
Discussion
Notwithstanding employment of some genetically based
models of PD in rodents and invertebrates, two main
experimental animal models of PD have been widely
used: (1) the selective degeneration of DA neurons
with the neurotoxins, such as N-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP, [37,38]) or 6-hydroxydopamine
(6-OHDA, [39]) and (2) the induction of degenerative
changes of DA neurons through precise transection of the
nigrostriatal afferent fibers [40]. The toxicity of MPTP and
6-OHDA is believed to result from inhibition of complex I
of the mitochondrial electron transport chain [41] and
could lead to acute and almost complete DA neuronal cell
death within a short time (1-3 days). However, the tran-
section of the adult rat MFB leads to different degrees and
rates of DA neuronal death. Our previous studies showed
that a time-dependent, progressive loss of DA neurons is
the main characteristic of the MFB transection model andthis surgical approach permitted axotomized neurons to
live for a significant length of time in situ; the statistically
significant decrease of DA neurons was observed from
7 days post-transection and about 40% of axotomized DA
neurons survived till 70 days after MFB transection
[26,42]. Therefore, MFB transection model is more
suitable to study the relationship between DA neuronal
degeneration and the surrounding environmental effects,
such as neuroglial function.
At 7 days after MFB transection, the protein level of TH
in the ipsilateral midbrain tended to decrease compared to
the contralateral side, but this decrease was not significant
by western blot assay (Figure 1). This result was not
consistent with our previous reports: at this time point,
when measured by unbiased stereological method, the
number of TH-ir neurons in the ipsilateral SN decreased
significantly about 10% [26,42]. This discrepancy could be
explained by the difference in methods used. In contrast
to the stereological method which confined the region of
interest to the SN, in western blot assay, the used tissue
block included the ventral tegmental area (VTA) as well
as SN. Therefore, the TH protein in the VTA might be
summed up in western blot assay and could mask the
decrease of TH protein level in the SN. The possibility
also cannot be ruled out that the remaining DA neurons
in the SN produce more TH protein to compensate the
loss of neighboring DA neurons. By and large, the total
amount of TH protein was decreased as time elapsed,
which means that progressive DA neuronal death occurred
following MFB transection.
The precise mechanism of axotomized DA neuronal
death is poorly understood, and it might be different
from other parkinsonian animal models, because MPTP
associated death is TUNEL-positive [43,44], while MFB
transection-induced cell death is TUNEL-negative [45,46].
Figure 3 Isolation of microglia from adult rat mesencephalon using density gradient fractionation. (A) Cellular pool from the midbrain of
10-week-old Wistar rat using OptiPrep step gradient separation method. The fraction and cellular designation were based on the previous study
[30]. Note the pellet at the bottom that contains microglia. (B) Double immunocytofluorescence labeling of Hoechst (nucleus) and one of the
microglial (OX42), astrocytic (GFAP), and neuronal (NeuN) markers using primary cultured cells obtained from the pellet in (A). Scale bar
represents 100 μm. (C) Semi-quantification of the number of OX42-ir, GFAP-ir, and NeuN-ir cells against Hoechst positive nuclei. The results are
expressed as the percentage of the number of OX42-ir, GFAP-ir, and NeuN-ir cells to the total number of Hoechst-ir nuclei. *P < 0.05 compared
with value from OX42-ir result (ANOVA with post hoc Student’s t test). (D) Immunocytofluorescence of OX6 and iNOS in primary cultured
microglia originated from the contralateral (Cont) or ipsilateral (Ipsi) SN at 7 dpl. Microglia cultivated from the ipsilateral SN are highly
immunoreactive with OX6 and iNOS, meaning that they are highly activated and produce high level of reactive nitrogen species. Scale bar
represents 20 μm.
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mechanism of axotomized DA neurons is entirely necrotic
[45,46]. However, we have presented some different opin-
ions that the mechanism of nigral cell death after axotomy
is another type of apoptosis, such as apoptosis-like
caspase-independent apoptosis [26,47]. The latter pos-
sibility is suggested by the findings that DAPI staining
showed apoptocic figures (i.e. chromatin clumps) in
axotomized DA neurons [47]. And many TH-ir neurons,
undergoing various steps of consecutive neurodegenerative
changes in the ipsilateral SN, retained phosphorylated c-Jun
and activating transcription factor 3 in the condensed or
fragmented nuclei [26]. It is widely accepted idea that c-Junphosphorylation triggers the cascades of programed cell
death in the injured dopaminergic neurons [48].
As the gradual DA neuronal death went on, to clear
the resultant cell debris and dead or dying neurons from
the CNS parenchyma, microglial activation was noted
in the ipsilateral SN. Morphologically activated microglia
(with large soma as well as shorten and thicken processes)
were crowded and they actively expressed MHC class II
(OX6-ir) and showed phagocytic characteristics (ED1-ir)
(Figure 1). Moreover, these activated microglia produced
ROS (O2
-and O2
- -derived oxidant) and showed a close
spatial relationship with collateral TH-ir DA neurons
(Figure 2). In this study, hydroethidine (also known as
Figure 4 Exogenous activated microglial transplantation into the ipsilateral SN accelerated the DA neuronal cell death. (A) TH
immunohistochemistry in the contralateral (Cont) and ipsilateral SN at 7 days after vehicle (Sham) or activated microglia (aMG) implantation. Scale
bar represents 300 μm. (B) Graph representing the relative percentage of the number of nigral TH-ir DA neurons. For quantitative analysis, every
fourth section among 40 μm serial brain sections was immunohistochemically stained with antibodies against TH, and the number of TH-ir
neurons were counted using a stereological technique in the whole SN. The percentage was analyzed by dividing the total number of TH-ir
neurons in the ipsilateral SN by that of the contralateral SN. Significant reduction in the number of SN TH-ir neurons of the aMG group,
compared with that of the vehicle treated group, indicates that transplantation of exogenous activated microglia into the ipsilateral SN
accelerates the axotomized DA neuronal cell death. Values were expressed as the mean ± S.E.M. (n = 6). *P < 0.05 compared with value from sham
control (ANOVA with post hoc Student’s t test).
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in situ. Hydroethidine is easily taken up by living cells
and shows blue fluorescence. Within the living cell,
hydroethidine can be directly oxidized in the presence
of ROS, such as O2
- , and then, it is converted to red
fluorescent ethidium, which in turn is trapped in the
cells by intercalation into DNA [32,49].
Microglial activation involves characteristic morpho-
logical transformation from resting to the activated
state, and activated microglia release ROS as well as
various proinflammatory and neurotoxic factors such
as tumor necrosis factor-alpha, interleukin-1beta and
so on. [2-5,50]. The ROS can cross cell membranes
easily and induce neuronal death by causing oxidative
damage to cellular components [51]. Actually, activated
microglia in culture secrete large amounts of H2O2 and
NO in a process known as ‘respiratory burst’, and candirectly damage cells and lead to neuronal cell death [52].
The potential clinical significance of this process has also
been highlighted by a postmortem study of PD patients,
which showed evidence of accumulation of activated
microglia and oxidative modifications of proteins in the SN
[53]. It is also well known that DA neurons in the SN pos-
sess reduced antioxidant capacity, such as accumulation of
total iron and low intracellular glutathione level [54,55],
which render DA neurons more vulnerable to oxidative
stress, relative to other cell types. Moreover, the number of
microglia is higher within the mesencephalon compared
with other brain areas [56]. Taken together, these findings
strongly suggest that the release of ROS from activated
microglia could increase neurotoxicity to adjacent DA
neurons and might contribute to neurodegeneration.
To confirm the role of activated microglia in DA
neuronal degeneration, we implanted activated microglia
Figure 5 Tuftsin fragment 1-3 decreased microglial activation and increased the survival rate of DA neurons. Tuftsin fragment 1-3 or
artificial CSF was administrated into the contralateral lateral ventricle using mini-osmotic pump for 14 and 28 days. (A) Western blot assay of OX6
and ED1 in the ipsilateral SN at 14 dpl following unilateral MFB transection and administration of tuftsin fragment 1-3 or artificial CSF. (B)
Quantification of results from western blot assay in (A). The density of each OX6 and ED1 band was normalized against that of beta-actin. Values
were normalized to control and expressed as the mean ± S.E.M. (n = 3). *P < 0.05 compared with value from control and #P < 0.05 compared with
value from sham control (ANOVA with post hoc Student’s t test). (C) OX6 and ED1 immunohistochemistry in the ipsilateral SN at 14 dpl following
unilateral MFB transection. In vehicle treated animals (Sham), innumerable OX6-ir and ED1-ir microglia are crowed in the ipsilateral SN. However,
in tuftsin fragment 1-3 treated animals (Tuft), the OX6 and ED1 immunoreactivities are deeply suppressed. Scale bar represents 250 μm. (D) Graph
representing the relative percentage of the number of nigral TH-ir DA neurons. For quantitative analysis, every fourth section among 40 μm serial
brain sections was immunohistochemically stained with antibodies against TH, and the number of TH-ir neurons were counted using a
stereological technique in the whole SN. The percentage was analyzed by dividing the total number of TH-ir neurons in the ipsilateral SN by that
of the contralateral SN. Values expressed as the mean ± S.E.M. (n = 7). *P < 0.05 compared with value from sham control (ANOVA with post hoc
Student’s t test).
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whether DA neuronal loss is accelerated. The most
popularly used microglial cell line is BV-2 but its appli-
cation is limited. For instance, BV-2 cells do not give re-
liable results in chemokine expression and release
following LPS treatment compared with primary micro-
glial cells. Moreover, it is natural that microglial cell line
cannot help having different biological characteristics
since its genetic immortalization might significantly
affect its biology [57,58]. Therefore, in this study, we
isolated adult primary microglia from rat brain 7 days
after MFB transection.
Previous microglia isolation methodologies generally
utilize whole brain regions. However, to utilize whole brain
seems to be inadequate. The brain microenvironment isextremely dynamic depending on its distinct anatomical re-
gions and the local neurochemical milieu [59]. Accordingly,
the microglial phenotype and activation state, especially
under pathological conditions, also have no choice but
to show heterogeneity and brain region specificity [60].
The phenotypic diversity displayed by CNS microglia
also reflects a functional diversity [61]. Thus, to isolate
microglia within interesting brain anatomical loci is thought
to be important to elucidate the exact role of microglia
in vivo. Therefore, in this study, we isolated activated
microglia from the adult rat midbrain of which MFB had
been transected 7 days before, and implanted the activated
microglia into the ipsilateral SN of the other rat directly of
which MFB also had been transected 7 days ago. To isolate
microglia from the SN region, we adapted Brewer and
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and culture adult rodent neurons [30]. We could isolate
highly enriched, quiescent microglia from adult rat SN.
Other CNS cell types such as astrocytes and neurons were
almost completely excluded (Figure 3). However, the exact
identity of Hoechst-positive spots which were not stained
with markers used in this study (OX42, NeuN, and GFAP)
was obscure. It may be that some nuclei of microglia were
not properly stained with OX42. Alternatively, it is possible
that the nuclear debris was merely detected with Hoechst
stain. In contrast to quiescent microglia isolated from
normal rat SN, microglia isolated from the ipsilateral SN
showed functionally activated phenotype possessing strong
MHC class II and iNOS immunoreactivity (Figure 3). These
results mean that the isolation procedure may not alter
the microglial immunophenotypes.
We directly transplanted the activated microglia into
the ipsilateral SN. So, the mechanical damage caused by
the inserted syringe may induce the additional innate
microglial activation. As a result, the ipsilateral SN, where
the activated microglia were transplanted and treated with
MFB transection 7 days ago, has three types of activated
microglial cells. The first is innate activated microglia
induced by MFB transection. The second is exogenous
activated microglia transplanted from other brains. And
the third is innate activated microglia induced by syringe
insertion. The effect of the first and the third can be
exclusory, because the sham controls had been also
received the same surgical procedures. Therefore, we could
assess the effect of exogenous activated microglia only, and
concluded that the transplantation of exogenous activated
microglia accelerates the axotomized DA neuronal death
significantly (Figure 4).
Tuftsin fragment 1-3, a human IgG derived tripeptide,
Thr-Lys-Pro, was first identified by Auriault and colleagues
[62]. Since its potential role as a macrophage inhibitory
factor was demonstrated, tuftsin fragment 1-3 has also
been used as a microglia inhibitory factor in other studies,
although its precise mechanism is unknown [28,63,64].
For example, Thanos and colleagues demonstrated that a
single intravitreal injection of tuftsin fragment 1-3 inhibited
phagocytic activity of microglia and increased the number
of regenerating axons of retinal ganglionic cells by two
to threefold [63]. Tuftsin fragment 1-3 also decreased
ROS production from activated microglia, resulting in a
promising reduction of brain edema and tissue damage
and attenuation of functional deficits in ischemic animal
brains [29].
In this study, we used tuftsin fragment 1-3 as a micro-
glial inhibitory factor to investigate the role of activated
microglia in the pathogenesis of axotomized DA neuronal
degeneration. In tuftsin fragment 1-3 treated animal, the
number and intensity of OX6-ir and ED1-ir activated
microglial cells were dramatically decreased and thesurvival rate of ipsilateral DA neurons was improved
about 20% compared with vehicle treated ones (Figure 5).
As a consequence, tuftsin fragment 1-3 was proved to be
an effective inhibitor of microglial activation and this
inhibitory effect was thought to contribute to the increased
survival rate of axotomized DA neurons.
Conclusion
There is much evidence that brain inflammation plays a
role in DA neuronal death in PD, although it is not
known whether it is primary or secondary, and microglia
are the main CNS cellular components which trigger and
modulate CNS neuroinflammation. In the present report,
we presented precise experimental evidences indicating
that highly activated microglia could lead to neurotoxicity
to axotomized DA neurons by producing ROS extensively.
Therefore, a well-controlled blockade of microglial activa-
tion might be neuroprotective in some neuropathological
conditions, if the neurons are potentially recoverable by
themselves or by effective neuroprotectants.
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